Nonalcoholic Fatty Liver Disease and Diabetes Are Associated with Decreased CYP3A4 Protein Expression and Activity in Human Liver-Reference-Cited by-同舟云学术

Nonalcoholic Fatty Liver Disease and Diabetes Are Associated with Decreased CYP3A4 Protein Expression and Activity in Human Liver

Published:2018-05-24 Issue:7 Volume:15 Page:2621-2632
ISSN:1543-8384
Container-title:Molecular Pharmaceutics
language:en
Short-container-title:Mol. Pharmaceutics

Author:

Jamwal Rohitash¹^ORCID,de la Monte Suzanne M.²,Ogasawara Ken¹,Adusumalli Sravani¹,Barlock Benjamin B.¹,Akhlaghi Fatemeh¹^ORCID

Affiliation:

1. Biomedical and Pharmaceutical Sciences, College of Pharmacy, University of Rhode Island, Kingston, Rhode Island 02881, United States

2. Departments of Medicine, Pathology, Neurology, and Neurosurgery, Rhode Island Hospital and the Warren Alpert Medical School of Brown University, Providence, Rhode Island 02903, United States

Funder

National Center for Advancing Translational Sciences

National Institute of General Medical Sciences

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Pharmaceutical Science,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.molpharmaceut.8b00159

Reference77 articles.

1. The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases

2. Diagnosis and classification of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis: Current concepts and remaining challenges

3. Nonalcoholic fatty liver disease: From steatosis to cirrhosis

4. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes

5. Insulin Resistance in Nonalcoholic Fatty Liver Disease

Cited by 92 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chlordecone-induced hepatotoxicity and fibrosis are mediated by the proteasomal degradation of septins;Journal of Hazardous Materials;2024-09

2. Unravelling the complexities of non-alcoholic steatohepatitis: The role of metabolism, transporters, and herb-drug interactions;Life Sciences;2024-08

3. Dynamic pattern of postprandial bile acids in paediatric non‐alcoholic fatty liver disease;Liver International;2024-07-31

4. THE ROLE OF PHARMACOGENOMIC STUDIES IN INCREASING THE EFFECTIVENESS AND SAFETY OF CLINICAL APPLICATION OF STATINS;Clinical and Preventive Medicine;2024-07-18

5. Decoding the Role of CYP450 Enzymes in Metabolism and Disease: A Comprehensive Review;Biomedicines;2024-07-02